2,9,25,32-TETRAOXO-4,7,27,30-TETRAKIS-(CARBOXYMETHYL)-1,4,7,10,24,27,30,33-OCTAAZA-[10.1.10.1]-PARACYCLOPHANE
Compound with spectra: 1 NMR
![2,9,25,32-TETRAOXO-4,7,27,30-TETRAKIS-(CARBOXYMETHYL)-1,4,7,10,24,27,30,33-OCTAAZA-[10.1.10.1]-PARACYCLOPHANE](/api/compound/7a1LtpaLdot.png?ph=true&h=300&w=458 "2,9,25,32-TETRAOXO-4,7,27,30-TETRAKIS-(CARBOXYMETHYL)-1,4,7,10,24,27,30,33-OCTAAZA-[10.1.10.1]-PARACYCLOPHANE")
| SpectraBase Compound ID | 7a1LtpaLdot |
|---|---|
| InChI | InChI=1S/C46H52N8O12/c55-39-23-51(27-43(59)60)17-18-52(28-44(61)62)25-41(57)49-37-13-5-33(6-14-37)22-34-7-15-38(16-8-34)50-42(58)26-54(30-46(65)66)20-19-53(29-45(63)64)24-40(56)48-36-11-3-32(4-12-36)21-31-1-9-35(47-39)10-2-31/h1-16H,17-30H2,(H,47,55)(H,48,56)(H,49,57)(H,50,58)(H,59,60)(H,61,62)(H,63,64)(H,65,66) |
| InChIKey | HFZGAJNVMGDLBF-UHFFFAOYSA-N |
| Mol Weight | 909.0 g/mol |
| Molecular Formula | C46H52N8O12 |
| Exact Mass | 908.370469 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O;PD=10.2 |
Ethyl 4-[2-oxo-2-(4-toluidino)ethyl]-1-piperazinecarboxylate
Methyl 4-(([4-(cyanomethyl)-1-piperazinyl]acetyl)amino)benzoate
2-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-N-[4-(trifluoromethoxy)phenyl]acetamide
1,4-piperazinediacetamide, N~1~-[4-(dimethylamino)phenyl]-N~4~-(4-ethoxyphenyl)-
1,4-piperazinediacetamide, N~1~-[4-(diethylamino)phenyl]-N~4~-(4-methoxyphenyl)-
piperazinediium, 1-[2-[[4-(chlorodifluoromethoxy)phenyl]amino]-2-oxoethyl]-4-(2-hydroxyethyl)-, dichloride
N-[4-[chloranyl-bis(fluoranyl)methoxy]phenyl]-2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanamide
Estane 5707 f 1
1,4-piperazinediacetamide, N~1~-(4-bromophenyl)-N~4~-(3-fluorophenyl)-
4-[(4-Methoxy-phenylcarbamoyl)-methyl]-piperazine-1-carboxylic acid ethyl ester
| Title | Journal or Book | Year |
|---|---|---|
| Molecular recognition of phenethylamine, tyramine and dopamine with new anionic cyclophanes in aqueous media | Journal of the Chemical Society, Perkin Transactions 2 | 1997 |